Capitalink Ltd. Fully Exits Position in Clearmind Medicine Inc. (CMND)

On May 15, 2026, Capitalink Ltd. filed a Schedule 13G/A (Amendment No. 3) with the SEC, reporting a complete exit from its position in Clearmind Medicine Inc. (CMND). The filing indicates that as of the event date on March 31, 2026, the reporting person no longer beneficially owns any common shares of the company. This represents a significant change from the previous reporting period, where Capitalink Ltd. held 107,943 shares, representing a 5.0% ownership stake. Capitalink Ltd., an Israeli-based entity, certified that the securities were not held for the purpose of influencing or changing the control of the issuer. The filing confirms that the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities. Consequently, the beneficial ownership percentage and the number of shares held with voting or dispositive power are now reported as zero. This final amendment effectively closes out Capitalink Ltd.'s reported position in Clearmind Medicine Inc. under this schedule.